Patent · US Active

Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same

US11584923B2 · kind B2 · utility

0Cited by
154References
53Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 29, 2018
Grant dateFeb 21, 2023
Priority date
Expiry dateJul 15, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are variant adenosine deaminase 2 (ADA2) proteins, conjugates thereof and compositions containing the proteins and/or conjugates. Also provided are methods and uses of the ADA2 proteins or conjugates for treating diseases and conditions, such as a tumor or cancer, and in particular any disease or condition associated with elevated adenosine or other associated marker.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.